Postoperative steroids after Kasai portoenterostomy for biliary atresia: a meta-analysis.

Abstract

AIM:

The aim of this systematic review and meta-analysis was to determine if adjunct steroids affect jaundice-free, cholangitis, and survival rates after Kasai portoenterostomy.

METHODS:

The literature was searched using the following terms: biliary atresia, portoenterostomy, steroids, glucocorticoids, dexamethasone, prednisolone, and hydrocortisone. The primary outcome was the jaundice-free rate. Secondary outcomes were cholangitis and survival rates.

RESULTS:

Ten studies were included in the systematic review and 8 in the meta-analyses. Steroid treatment regimens were inconsistent between studies. The pooled odds ratio (OR) for the jaundice-free rate did not significantly favor steroid over non-steroid treatment (1.95; 95% confidence interval [CI]: 0.91-4.11; P = 0.087), nor did the pooled OR for the cholangitis rate (0.75; 95% CI: 0.48-1.17; P = 0.202). Overall survival ranged from 58 to 95% in the steroid group and from 36 to 96% in the control group. Native liver survival ranged from 30 to 56% in the steroid group and from 31 to 48% in the control group. The survival data were not suitable for meta-analysis.

CONCLUSIONS:

Although these results imply that adjunct steroids after Kasai portoenterostomy for BA may not improve jaundice-free or cholangitis rates, the quality of available evidence is limited and therefore not definitive. Additional high quality studies are needed.

• Authors: Da Zhang, He-ying Yang, Jia Jia, Ge Zhao, Ming Yue, Jia-xiang Wang
• Journal: International journal of surgery (London, England) (Int J Surg) Vol. 12 Issue 11 Pg. 1203-9 (Nov 2014) ISSN: 1743-9159 [Electronic] England
• PMID: 25224699 (Publication Type: Journal Article, Meta-Analysis, Review, Systematic Review)
• Copyright: Copyright © 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Chemical References

• Glucocorticoids
• Dexamethasone
• Prednisolone
• Hydrocortisone

Topics

• Biliary Atresia (complications, mortality, surgery)
• Cholangitis (epidemiology, prevention & control)
• Dexamethasone (therapeutic use)
• Glucocorticoids (therapeutic use)
• Humans
• Hydrocortisone (therapeutic use)
• Jaundice (epidemiology, prevention & control)
• Portoenterostomy, Hepatic
• Postoperative Care
• Prednisolone (therapeutic use)
• Survival Rate